Table 1.
Venous thromboembolism (VTE) associated with specific types of cancer.
| Cancer | California: cumulative incidence of VTE (%) 1 year (n) | California: rate of VTE (/100 patient-years) | Netherlands: cumulative incidence 6 months (n) | USA: hospitalized Medicare patients, prevalence 6 months (n) |
|---|---|---|---|---|
| Pancreas | 5.3% (6524) | 14.0% | 2.3% (1674) | 1.2% (41 551) |
| Brain | 6.9% (3775) | 11.1% | 3.2% (1058) | 1.2% (13 529) |
| Acute myelogenous leukaemia | 3.7% (2292) | 7.4% | 1.9% (532) | - |
| Stomach | 4.5% (5766) | 7.4% | 1.5% (2337) | 0.9% (32 655) |
| Oesophagus | 3.6% (2491) | 5.8% | 1.3% (1040) | 0.4% (14 742) |
| Renal cell | 3.5% (4891) | 4.3% | 1.3% (1503) | 0.8% (34 375) |
| Lung | 2.4% (44 497) | 4.3% | 1.4% (9336) | 0.6% (232 764) |
| Ovary | 3.3% (5707) | 4.2% | 3.3% (1444) | 1.2% (26 406) |
| Liver | 1.7% (2312) | 4.1% | 0.7% (970) | 0.7% (22 938) |
| Lymphoma | 2.8% (9003) | 3.7% | 2.0% (2470) | 1.0% (52 042) |
| Chronic lymphocytic leukaemia | 2.7% (2023) | 3.1% | 1.7% (524) | - |
| Acute lymphocytic leukaemia | 2.6% (1058) | 3.1% | 1.7% (168) | - |
| Colon | 2.3% (32 611) | 2.7% | 1.3% (6262) | 0.8% |
| Chronic myelogenous leukaemia | 1.5% (951) | 1.8% | 0.6% (165) | - |
| Bladder | 1.5% (7138) | 1.7% | 1.3% (2250) | 0.2% (168 832) |
| Uterus | 1.6% (8721) | 1.7% | 1.1% (1431) | 0.4% (11 606) |
| Prostate | 0.9% (51362) | 1.0% | 0.9% (6013) | 0.5% (218743) |
| Breast | 0.9% (44707) | 0.9% | 0.8% (10566) | 0.2% (186273) |
| Melanoma | 0.5% (9497) | 0.5% | 0.3% (2236) | - |